Antibody-Drug Conjugate (ADC) Design and Testing
At Mastering Up, we provide specialized training in Antibody-Drug Conjugate (ADC) Design and Testing, designed to equip participants with the knowledge and skills to develop targeted therapeutic agents combining monoclonal antibodies with cytotoxic drugs. This program covers ADC design principles, linker chemistry, conjugation strategies, and preclinical testing for efficacy and safety.
Participants will gain practical insights into antibody selection, payload optimization, in vitro and in vivo testing, and analytical techniques for characterizing ADCs. The course emphasizes applications in oncology, targeted therapy development, and translational research.
What We Offer:
Comprehensive Curriculum: Covers ADC design, antibody-payload conjugation, linker chemistry, and therapeutic evaluation protocols.
Hands-On Practice: Practical sessions on conjugation techniques, characterization assays, and efficacy testing.
Application Insights: Case studies in targeted cancer therapy, biomarker selection, and translational research strategies.
Data Interpretation: Guidance on analyzing cytotoxicity, binding affinity, pharmacokinetics, and therapeutic efficacy.
Why Choose Mastering Up?
Expert instructors with experience in antibody engineering, drug conjugation, and translational oncology research.
Interactive sessions combining theoretical concepts, laboratory techniques, and data analysis exercises.
Certification upon completion, validating your expertise in ADC design and testing.
Trusted by pharmaceutical companies, research institutes, and biotech organizations worldwide.
Develop the skills to design, optimize, and evaluate antibody-drug conjugates for targeted therapeutic applications.
Partner with Mastering Up to master Antibody-Drug Conjugate (ADC) Design and Testing.
